Brownstein Catherine A, Douard Elise, Haynes Robin L, Koh Hyun Yong, Haghighi Alireza, Keywan Christine, Martin Bree, Alexandrescu Sanda, Haas Elisabeth A, Vargas Sara O, Wojcik Monica H, Jacquemont Sébastien, Poduri Annapurna H, Goldstein Richard D, Holm Ingrid A
Robert's Program on Sudden Unexplained Death in Pediatrics Boston Children's Hospital Boston MA 02115 USA.
Division of Genetics and Genomics Boston Children's Hospital Boston MA 02115 USA.
Adv Genet (Hoboken). 2022 Nov 7;4(1):2200012. doi: 10.1002/ggn2.202200012. eCollection 2023 Mar.
In sudden unexplained death in pediatrics (SUDP) the cause of death is unknown despite an autopsy and investigation. The role of copy number variations (CNVs) in SUDP has not been well-studied. Chromosomal microarray (CMA) data are generated for 116 SUDP cases with age at death between 1 and 28 months. CNVs are classified using the American College of Medical Genetics and Genomics guidelines and CNVs in our cohort are compared to an autism spectrum disorder (ASD) cohort, and to a control cohort. Pathogenic CNVs are identified in 5 of 116 cases (4.3%). Variants of uncertain significance (VUS) favoring pathogenic CNVs are identified in 9 cases (7.8%). Several CNVs are associated with neurodevelopmental phenotypes including seizures, ASD, developmental delay, and schizophrenia. The structural variant 47,XXY is identified in two cases (2/69 boys, 2.9%) not previously diagnosed with Klinefelter syndrome. Pathogenicity scores for deletions are significantly elevated in the SUDP cohort versus controls ( = 0.007) and are not significantly different from the ASD cohort. The finding of pathogenic or VUS favoring pathogenic CNVs, or structural variants, in 12.1% of cases, combined with the observation of higher pathogenicity scores for deletions in SUDP versus controls, suggests that CMA should be included in the genetic evaluation of SUDP.
在儿科不明原因猝死(SUDP)中,尽管进行了尸检和调查,死亡原因仍不明确。拷贝数变异(CNV)在SUDP中的作用尚未得到充分研究。对116例死亡年龄在1至28个月之间的SUDP病例进行了染色体微阵列(CMA)数据检测。根据美国医学遗传学与基因组学学会的指南对CNV进行分类,并将我们队列中的CNV与自闭症谱系障碍(ASD)队列以及对照队列进行比较。在116例病例中有5例(4.3%)鉴定出致病性CNV。在9例病例(7.8%)中鉴定出倾向于致病性CNV的意义未明变异(VUS)。几种CNV与神经发育表型有关,包括癫痫、ASD、发育迟缓及精神分裂症。在两例之前未诊断为克兰费尔特综合征的病例(2/69名男孩,2.9%)中鉴定出结构变异47,XXY。与对照组相比,SUDP队列中缺失的致病性评分显著升高(P = 0.007),且与ASD队列无显著差异。在12.1%的病例中发现致病性或倾向于致病性CNV的VUS或结构变异,再加上观察到SUDP中缺失的致病性评分高于对照组,这表明CMA应纳入SUDP的基因评估中。